Depends how one wants to look at it. The negatives are legacy problems and unlikely they will be repeated. This has caused negative cashflow - first for this business.
It had a cost problem FY22-23 and may need to cut deeper
New markets didnt grow in FY23 which was disappointing. Anything sub $US100m revenue for new markets is a poor result.
Lots of non legacy positives and a pathway to growth next 12-24 months.
How much legacy is factored in and how much non legacy is factored in - only the market will tell us.
Ann: Appen 2023 Full Year Results & 2024 Outlook, page-13
-
- There are more pages in this discussion • 121 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add APX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.8¢ |
Change
0.008(1.63%) |
Mkt cap ! $102.5M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 46.8¢ | 46.5¢ | $6.709K | 14.42K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 80397 | 46.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 1960 | 1 |
View Market Depth
| Last trade - 10.00am 23/07/2024 (20 minute delay) ? |
| APX (ASX) Chart |